Commercialization of low-toxicity propellant based on HAN
First written in FY2016. 28 of 32 entries say "Restated". Latest entry: FY2027-H1.
No other company in this theme has enough history to compare yet.
- FY2027-H1RestatedAnnual report
「Research and development expenditures during the interim accounting period amounted to ¥7.586 million.」
Research and development activities related to the commercialization of low-toxicity propellant based on HAN are continuing, but no specific significant changes have been disclosed. - FY2026RestatedAnnual report
「We also continue to supply low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN) to research institutions, universities, and others in Japan, and continue research toward its commercialization as propellant for attitude control of satellites.」
The company continues to supply HAN-based low-toxicity propellant to research institutions, universities, and others and conduct commercialization research as satellite propellant. - FY2026-H1RestatedAnnual report
「Research and development expenditure for the interim accounting period was ¥9.250 million.」
Research and development activities related to the commercialization of low-toxicity propellant based on HAN are continuing, but no specific significant changes have been disclosed. - FY2025RestatedAnnual report
「For low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), we continue to supply research institutions, universities, and others in Japan and conduct research toward its commercialization as satellite propellant.」
The company continues to supply HAN-based low-toxicity propellant to research institutions, universities, and others in Japan and conduct commercialization research for use in satellites. - FY2025-H1RestatedAnnual report
「Research and development expenditure for the interim accounting period was ¥5.354 million.」
Commercialization research on low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2024AdvancedAnnual report
「For multiple types of low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), we continue to supply small quantities to research institutions, universities, and others in Japan, contributing to research toward commercialization as satellite propellant.」
For HAN-based low-toxicity propellant, the company has disclosed that it continues to supply small quantities to domestic research institutions, universities, and others and contribute to commercialization research for use in satellites. - FY2024-Q3RestatedAnnual report
「Research and development expenditure for the nine-month period ended this quarter was ¥5.950 million.」
Commercialization research on low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2024-Q2RestatedAnnual report
「Research and development expenditure for the six-month period ended this quarter was ¥5.057 million.」
Commercialization research on low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2023RestatedAnnual report
「We continue to conduct safety evaluation tests in cooperation with research institutions and companies on multiple types of low-toxicity propellants (green propellants) based on hydroxylammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), and to pursue research toward their practical application as satellite propellants.」
For HAN-based low-toxicity propellant, the company continues safety assessment testing and commercialization research for use in satellites. - FY2023-Q3RestatedAnnual report
「Research and development expenditure for the nine-month period ended this quarter was ¥6.747 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2023-Q2RestatedAnnual report
「Research and development expenditure for the six-month period ended this quarter was ¥3.575 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2022RestatedAnnual report
「For low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), we are conducting safety assessment tests in collaboration with research institutions and continuing research toward its commercialization as satellite propellant.」
For HAN-based low-toxicity propellant, the company continues collaboration with research institutions, safety assessment testing, and commercialization research for use in satellites. - FY2022-Q3RestatedAnnual report
「Research and development expenditure for the nine-month period ended this quarter was ¥4.507 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2022-Q2RestatedAnnual report
「Research and development expenditure for the six-month period ended this quarter was ¥3.005 million.」
Commercialization research on low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2022-Q1RestatedAnnual report
「Research and development expenditure for the three-month period ended this quarter was ¥1.504 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2021RestatedAnnual report
「For multiple types of low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), which we have researched continuously, we are continuing research toward commercialization as satellite propellant in collaboration with research institutions and companies.」
For HAN-based low-toxicity propellant, the company continues commercialization research for use in satellites in collaboration with research institutions and companies. No progress such as a new practical testing stage has been disclosed. - FY2021-Q3RestatedAnnual report
「Research and development expenditure for the nine-month period ended this quarter was ¥6.485 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2021-Q2RestatedAnnual report
「Research and development expenditure for the six-month period ended this quarter was ¥4.485 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2021-Q1RestatedAnnual report
「Research and development expenditure for the three-month period ended this quarter was ¥2.116 million.」
Research and development related to the commercialization of low-toxicity propellant based on HAN is continuing, but no specific significant changes have been disclosed. - FY2020AdvancedAnnual report
「For low-toxicity propellant based on hydroxyl ammonium nitrate (Hydroxyl Ammonium Nitrate; HAN), which we have researched continuously, we are conducting safety assessment tests, including material compatibility tests, in collaboration with research institutions and companies, and continuing research toward its commercialization as satellite propellant. Following the launch in January last year, we are continuing research and development in cooperation with relevant organizations to load HAN-based propellant with a new composition onto a demonstration satellite.」
For HAN-based low-toxicity propellant, the company is conducting safety assessment tests, including material compatibility tests, and continuing research and development toward the stage of loading a new composition onto a demonstration satellite. - FY2020-Q3RestatedAnnual report
「Research and development expenditure for the nine-month period ended this quarter was ¥6 million. There have been no material changes in the status of the company's research and development during this period.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2020-Q2RestatedAnnual report
「Research and development expenditure for the six-month period ended this quarter was ¥4 million.」
No specific significant changes have been disclosed concerning research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2020-Q1RestatedAnnual report
「There have been no material changes in the status of the company's research and development during this period.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2019AdvancedAnnual report
「The propellant is also at the practical testing stage for use in rockets and satellites, and we will continue research and development and improvement activities concerning manufacturing methods, manufacturing technologies, and related matters.」
The company states that HAN-based propellant has reached the practical testing stage for use in rockets and satellites, representing specific progress. - FY2019-Q3RestatedAnnual report
「There have been no material changes in the status of the company's research and development during the nine-month period ended this quarter.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2019-Q2RestatedAnnual report
「There have been no material changes in the status of the company's research and development during this period.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2019-Q1RestatedAnnual report
「There have been no material changes in the status of the company's research and development during this period.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2018RestatedAnnual report
「We will continue research and development on manufacturing methods, manufacturing technologies, and related matters to commercialize it as propellant for rockets and satellites.」
The company continues research and development on manufacturing methods and technologies aimed at commercializing HAN-based propellant for rockets and satellites. - FY2018-Q3RestatedAnnual report
「There have been no material changes in the status of the company's research and development during the nine-month period ended this quarter.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2018-Q2RestatedAnnual report
「There have been no material changes in the status of the company's research and development during this period.」
The company has reaffirmed that there have been no significant changes to its research and development related to the commercialization of low-toxicity propellant based on HAN. - FY2017RestatedAnnual report
「We will continue research and development on manufacturing methods, manufacturing technologies, and related matters to commercialize it as propellant for rockets and satellites.」
The company has reaffirmed its policy of continuing research and development on manufacturing methods and technologies for low-toxicity propellant based on HAN. - FY2016First statedAnnual report
「We continue research and development on manufacturing methods, manufacturing technologies, and related matters with a view to commercializing it as satellite propellant in the near future.」
For propellant based on HAN, the company is advancing synthesis and analysis, safety assessments, and supply to research institutions and companies, with the goal of commercializing it as satellite propellant.